Reports

Ideas That Generate Results

List of Figures:

Figure 3-1: India API Market Trade (%), 2009-2014
Figure 3-2: Top 5 API Markets of the World (%), 2014
Figure 3-3: Share of India in Global API Market (%), 2014
Figure 3-4: India API Market (Billion US$), 2009-2014
Figure 4-1: Healthcare Expenditure (% of GDP), 2009-2014
Figure 4-2: Personal Disposable Income (Billion US$), 2009-2014
Figure 4-3: Population Above 65 years (Million), 2009-2014
Figure 4-4: Diabetes Population in the Age Group 20-79 years (Million), 2013 & 2030
Figure 4-5: Number of Cancer Cases (‘000), 2014 & 2020
Figure 5-1: Share of Captive and Merchant Market APIs in Indian API Market (%), 2014
Figure 5-2: Share of Branded and Generic Drug APIs in Indian API Market (%), 2014
Figure 5-3: Share of Chemical/Small Molecule and Biotech APIs in Indian API Market (%), 2014
Figure 5-4: Share of APIs by their Application in Therapeutic Areas in Indian API Market (%), 2014
Figure 8-1: API License Procedure
Figure 9-1: Sun Pharma- Break up of Revenue by Therapeutic Segment (%), 2014
Figure 9-2: Sun Pharma- Break up of Revenue by Geography (%), 2014
Figure 9-3: Cipla Limited-Break up of Revenue by Geography (%), 2014
Figure 9-4: Biocon-Break up of Revenue by Geography (%), 2014
Figure 9-5: Dr. Reddy's Laboratories - Break up of Revenue by Geography (%), 2014
Figure 9-6: Lupin Limited- Revenues by Trade (Billion US$), 2014
Figure 9-7: Aurobindo Pharma Limited - Break up of Revenue of Formulations by Geography (%), 2014
Figure 9-8: Wockhardt- Break up of Revenue by Geography (%), 2014
Figure 9-9: Zydus Cadila- Break up of Revenue by Geography (%), 2014
Figure 9-10: Glenmark- Break up of Revenue by Geography (%), 2014
Figure 9-11: Jubilant LifeSciences- Break up of Revenue by Geography (%), 2014
Figure 10-1: Indian API Market (Billion US$), 2015-2020

List of Tables:

Table 3-1: Top 10 APIs in the Indian API Market (2014)
Table 4-1: List of Blockbuster Drugs Losing Patent (2015-2020)
Table 4-2: API Import from China (2011-2015)
Table 6-1: Mergers and Acquisitions in Indian Pharma Industry (2014-2015)
Table 9-1: Sun Pharma- Revenues by Business Segment (Billion US$), 2013 & 2014
Table 9-2: Biocon-Revenues by Business Segment (Billion US$), 2013 & 2014
Table 9-3: Dr. Reddy's Laboratories - Revenues by Business Segment (Billion US$), 2013 & 2014
Table 9-4: Lupin Limited- Revenues by Business Segment (Billion US$), 2013 & 2014
Table 9-5: Aurobindo Pharma Limited - Revenues by Business Segment (Billion US$), 2013 & 2014
Table 9-6: Wockhardt- Revenue by Business Segment (Billion US$), 2013 & 2014
Table 9-7: Zydus Cadila- Revenues by Business Segment (Billion US$), 2013 & 2014
Table 9-8: Glenmark- Revenues by Business Segment (Billion US$), 2013 & 2014
Table 9-9: Jubilant LifeSciences- Revenues by Business Segment (Billion US$), 2013 & 2014